← Eichor
Condition: Advanced Gastrointestinal Stromal Tumor Gist Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Advanced Gastrointestinal Stromal Tumor Gist

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (G
Phase 2 · 13 location(s) · Centre Leon Berard · NCT05009927PH 2 Pemigatinib in SDH-deficient GIST
Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT07434843KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Lin
Phase 2 · 16 location(s) · Kumquat Biosciences Inc. · NCT07406633A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Phase 1/Phase 2 · 28 location(s) · Deciphera Pharmaceuticals, LLC · NCT05957367A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Phase 1/Phase 2 · 4 location(s) · Cancer Research UK · NCT06380816Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Phase 2/Phase 3 · 32 location(s) · Ningbo Newbay Technology Development Co., Ltd · NCT07379047Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST
NA · 1 location(s) · First Affiliated Hospital of Chongqing Medical University · NCT06507683A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizu
Phase 2 · 13 location(s) · Centre Leon Berard · NCT05152472(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Phase 3 · 126 location(s) · Cogent Biosciences, Inc. · NCT05208047Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor
Phase 2 · 84 location(s) · Merck Sharp & Dohme LLC · NCT04924075Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients
Phase 1/Phase 2 · 1 location(s) · Asan Medical Center · NCT07096609The Efficacy and Safety of Temozolomide in SDH-deficient GIST
Phase 2 · 1 location(s) · Asan Medical Center · NCT05661643Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
NA · 1 location(s) · Xiangya Hospital of Central South University · NCT05751733Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment
Phase N/A · 1 location(s) · The Netherlands Cancer Institute · NCT07522762A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Expres
Phase 1 · 5 location(s) · Novelty Nobility, Inc. · NCT06805825A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Phase 1 · 32 location(s) · Kura Oncology, Inc. · NCT06655246A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Parti
Phase 2 · 54 location(s) · Bayer · NCT06760819
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.